UK markets closed
NIKKEI 225
38,073.98 -128.39 (-0.34%) HANG SENG
18,537.81 +223.95 (+1.22%) CRUDE OIL
79.56 +0.57 (+0.72%) GOLD FUTURES
2,347.30 +25.00 (+1.08%) DOW
39,408.38 +351.99 (+0.90%) Bitcoin GBP
49,753.00 +20.90 (+0.04%)
BSF Enterprise Plc (BSFA.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 02:58PM BST
| Previous close | 5.0000 |
| Open | 4.6300 |
| Bid | 0.0000 x N/A |
| Ask | 5.5000 x N/A |
| Day's range | 4.6300 - 5.4500 |
| 52-week range | 4.5000 - 16.9000 |
| Volume | |
| Avg. volume | 644,213 |
| Market cap | 5.167M |
| Beta (5Y monthly) | 1.78 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0200 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Globe NewswireBSF Enterprise PLC Provides City-MixTM Bio-Pharmaceutical Update
LONDON, July 18, 2023 (GLOBE NEWSWIRE) -- BSF Enterprise PLC ("BSF" or the "Company") (LSE: BSFA), (OTCQB: BSFAF), a company focused on unlocking the next generation of biotechnological solutions using cell-based tissue engineering, today provides a commercial update on the progress of City-MixTM, the flagship commercial product of its wholly owned subsidiary 3D Bio Tissues (3DBT). 3DBT's City-MixTM is a patented non-toxic culture media supplement that acts as an effective 'cell booster'. It is
© 2024 Yahoo. All rights reserved.